Sign in Pull a receipt

KRYS

Krystal Biotech, Inc.

Healthcare · Biotechnology

$110.22 sample

+1.02 (+0.93%) 1D

Market cap

$92.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-16

Alerts

8

Price$110.22 +14.04% 3M daily closessample

110.2296.65

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Chief Executive Officer
Oct 16SEC10-Q filed
Oct 07INSInsider buy: 10% owner
Oct 02SECForm 144 filed
Sep 25INSInsider buy: Director
Sep 17INSInsider sell: General Counsel
Sep 08INSInsider sell: Chief Executive Officer
Sep 02INSInsider buy: Chief Executive Officer

Sign up to see the real KRYS record →

Company facts

SEC EDGAR registration

Name: Krystal Biotech, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -50sample, -100 to +100
Reporting currency: USD

Who is positioning in KRYS

sample

Insiders: 27 insider transactions over 90 days, net selling, $50.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 36 funds hold $818.0M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.5B +13.9% y/y

Q4 2024Q3 2026

Inventory$2.1B +8.9% y/y

Q4 2024Q3 2026

Accounts receivable$1.6B +11.5% y/y

Q4 2024Q3 2026

Total debt$4.1B +4.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $39.2B +6.3% 3M
Sample peer B: $34.3B -7.5% 3M
Sample peer C: $31.0B -0.5% 3M
Sample peer D: $47.2B -5.7% 3M
Sample peer E: $20.3B -2.5% 3M